Assignee
TENEOONE INC
US·3 granted patents·6 pending applications·17 citations·filing 2018–2025
Top patents by PatentIndex Score
9 records- 0194US11186639B2Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2021·Granted Nov 30, 2021·7 cites·20 claims
- 0293US11421027B2CD3 binding antibodiesTENEOONE INC·Filed 2021·Granted Aug 23, 2022·6 cites·17 claims
- 0385US11427642B2Anti-BCMA heavy chain-only antibodiesTENEOONE INC·Filed 2018·Granted Aug 30, 2022·4 cites·13 claims
- 0483US2025066476A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2023·Application pending·0 cites
- 0577US2025340638A1Cd3 binding antibodiesTENEOONE INC·Filed 2025·Application pending·0 cites
- 0677US2023082151A1Cd3 binding antibodiesTENEOONE INC·Filed 2022·Application pending·0 cites
- 0774US2022332820A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2021·Application pending·0 cites
- 0865US2025177520A1Methods for the treatment of multiple myelomaTENEOONE INC·Filed 2024·Application pending·0 cites
- 0965US2023060847A1Anti-bcma heavy chain-only antibodiesTENEOONE INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →